Bevacizumab for non-small cell lung cancer patients with brain metastasis: A meta-analysis

This study evaluates the efficacy and safety of bevacizumab (BEV) in the treatment of non-small cell lung cancer (NSCLC) patients with brain metastases (BM) by performing meta-analyses of response and survival indices. Seventeen studies were included. BEV treatment was associated with a lower new BM...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Ping, Wang, Yu-Dong, Wei, Zong-Min, Deng, Qi-Jun, Xu, Tong, Liu, Jiang, Luo, Na, Hou, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706125/
https://www.ncbi.nlm.nih.gov/pubmed/33313410
http://dx.doi.org/10.1515/med-2020-0192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706125/
https://www.ncbi.nlm.nih.gov/pubmed/33313410
http://dx.doi.org/10.1515/med-2020-0192

Ejemplares similares